These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33821666)

  • 41. Introduction to sacral neuromodulation therapy for urinary bladder dysfunction using an InterStim system.
    Harries F
    Br J Nurs; 2020 May; 29(9):S23-S26. PubMed ID: 32407234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sacral neuromodulation for overactive bladder using the InterStim and BetterStim systems.
    Meng L; Tian Z; Zhang Y; Wang J; Liao L; Chen G; Tian X; Ma L; Li Y; Shi B; Zhang Y; Ling Q; Zhang P; Wei Z; Zhong T; Xu Z; Li J; Luo D
    Sci Rep; 2022 Dec; 12(1):22299. PubMed ID: 36566332
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What Is New in Neuromodulation?
    Moore CK; Rueb JJ; Derisavifard S
    Curr Urol Rep; 2019 Aug; 20(9):55. PubMed ID: 31388779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sacral neuromodulation and intravesical botulinum toxin for refractory overactive bladder.
    Kantartzis K; Shepherd J
    Curr Opin Obstet Gynecol; 2012 Oct; 24(5):331-6. PubMed ID: 22922403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New Technologies and Applications in Sacral Neuromodulation: An Update.
    De Wachter S; Knowles CH; Elterman DS; Kennelly MJ; Lehur PA; Matzel KE; Engelberg S; Van Kerrebroeck PEV
    Adv Ther; 2020 Feb; 37(2):637-643. PubMed ID: 31875299
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selection of ideal candidates for neuromodulation in refractory overactive bladder.
    Kacker R; Das AK
    Curr Urol Rep; 2010 Nov; 11(6):372-8. PubMed ID: 20821358
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Longitudinal Fluctuations in Treatment Response After OnabotulinumToxinA and Sacral Neuromodulation for Refractory Urgency Incontinence.
    Hendrickson WK; Zhang C; Jelovsek JE; Nygaard IE; Presson AP
    J Urol; 2024 Jan; 211(1):134-143. PubMed ID: 37871326
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes of Sacral Neuromodulation in Patients with Prior Surgical Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse.
    Bartley JM; Ramirez V; Killinger KA; Boura JA; Gupta P; Gaines N; Gilleran JP; Peters KM
    Female Pelvic Med Reconstr Surg; 2017; 23(1):8-12. PubMed ID: 27636222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of sacral neuromodulation on pudendal nerve function and female sexual function.
    Parnell BA; Howard JF; Geller EJ
    Neurourol Urodyn; 2015 Jun; 34(5):456-60. PubMed ID: 24615871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sacral Neuromodulation is Preferred over OnabotulinumtoxinA Injection for Overactive Bladder in Women: Con.
    Bales GT
    J Urol; 2017 Sep; 198(3):500-501. PubMed ID: 28751016
    [No Abstract]   [Full Text] [Related]  

  • 51. Sacral Neuromodulation is Preferred over OnabotulinumtoxinA Injection for Overactive Bladder in Women: Pro.
    Kraus SR
    J Urol; 2017 Sep; 198(3):501-502. PubMed ID: 28751015
    [No Abstract]   [Full Text] [Related]  

  • 52. Neuromodulation for the Treatment of Lower Urinary Tract Symptoms.
    Yamanishi T; Kaga K; Fuse M; Shibata C; Uchiyama T
    Low Urin Tract Symptoms; 2015 Sep; 7(3):121-32. PubMed ID: 26663726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Baseline symptom severity and therapeutic success in a large prospective trial of sacral neuromodulation therapy for overactive bladder patients.
    Noblett K; Berg KC; Kan F; Siegel S
    Neurourol Urodyn; 2018 Jun; 37(5):1667-1671. PubMed ID: 29635879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Therapy-refractory overactive bladder: alternative treatment approaches].
    Knüpfer S; Hamann M; Naumann CM; Melchior D; Jünemann KP
    Urologe A; 2011 Jul; 50(7):806-9. PubMed ID: 21725649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prospective Trial of Sacral Neuromodulation for Refractory Overactive Bladder Syndrome in Korean Patients.
    Moon KH; Han JY; Kim JH; Lee HN; Lee KS; Lee JG; Oh SJ; Yoon HN; Choo MS
    Low Urin Tract Symptoms; 2014 Sep; 6(3):175-9. PubMed ID: 26663601
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment for refractory non-neurogenic overactive bladder].
    Gamé X; Phé V
    Prog Urol; 2020 Nov; 30(14):920-930. PubMed ID: 33220820
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children.
    Barroso U; Viterbo W; Bittencourt J; Farias T; Lordêlo P
    J Urol; 2013 Aug; 190(2):673-7. PubMed ID: 23422257
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Initial experience using the Axonics sacral neuromodulation system in patients with multiple sclerosis.
    Chen A; Kapur A; Mossack S; Weissbart SJ; Kim JM
    Neurourol Urodyn; 2022 Aug; 41(6):1373-1379. PubMed ID: 35579263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sacral nerve stimulation reduces elevated urinary nerve growth factor levels in women with symptomatic detrusor overactivity.
    Shalom DF; Pillalamarri N; Xue X; Kohn N; Lind LR; Winkler HA; Metz CN
    Am J Obstet Gynecol; 2014 Nov; 211(5):561.e1-5. PubMed ID: 25019486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sleep disturbance changes in women after treatment of refractory overactive bladder with sacral neuromodulation.
    Sanderson DJ; Gevelinger M; Jaworski E; Doyle PJ
    Investig Clin Urol; 2020 Mar; 61(2):231-237. PubMed ID: 32158975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.